45 results
Page 2 of 3
6-K
EX-99.2
vo7xowamztw80t
3 Apr 23
Consolidated Financial Statements
6:05am
424B3
a0zgo1p4m30wzqq3h
14 Nov 22
Prospectus supplement
1:51pm
6-K
EX-99.2
0ekq8rawqbziuajyyq
14 Nov 22
Condensed Interim Consolidated Financial Statements
1:04pm
424B4
qbajgqgwr6w2w7eyd2
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
e8n eok5z
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
8u0 kju7aycl2gauqv
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1
o8930pg21o7ilmho8
8 Sep 22
Registration statement (foreign)
1:02pm
DRS
yw3a98gx35lpniuji9
15 Aug 22
Draft registration statement
12:00am
6-K
EX-99.2
wlx307 4o08nlytno
11 Aug 22
Condensed Interim Consolidated Financial Statements
7:00am
6-K
EX-99.2
oi2ank 4s5yp9
16 May 22
Condensed Interim Consolidated Financial Statements
7:25am
20-F
EX-4.20
iy2pmtz
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-11.1
c3wpg tehx5vo
3 May 22
Annual report (foreign)
5:29pm
20-F
fpvc6149uj57
3 May 22
Annual report (foreign)
5:29pm
6-K
EX-99.1
vx1g2erfiv1
13 Apr 22
Current report (foreign)
7:23am
6-K
EX-99.2
33wf3zh
10 Jan 22
XORTX to Participate in H.C. Wainwright BioConnect 2022 Virtual Conference
7:01am
6-K
EX-99.1
iat9ywb
23 Nov 21
XORTX Therapeutics Announces Annual and Special Meeting of Shareholders
7:21am
424B4
4voqp8wyls 3m8a3b
14 Oct 21
Prospectus supplement with pricing info
4:30pm
F-1/A
dv3hd4lo3xp
4 Oct 21
Registration statement (foreign) (amended)
12:00am
F-1/A
fw1w3rp sfm3m3
16 Sep 21
Registration statement (foreign) (amended)
5:16pm
F-1
5l0hs
11 Aug 21
Registration statement (foreign)
9:55pm